Reuters logo
BRIEF-Theraclion to present data from the U.S. pilot trial of echotherapy with Echopulse
November 20, 2017 / 7:14 AM / 22 days ago

BRIEF-Theraclion to present data from the U.S. pilot trial of echotherapy with Echopulse

Nov 20 (Reuters) - THERACLION SA

* ANNOUNCES THE PRESENTATION OF DATA FROM THE U.S. PILOT TRIAL OF ECHOTHERAPY WITH ECHOPULSE®

* ‍RESULTS SUGGEST POSITIVE OUTCOME OF ONGOING PIVOTAL TRIAL OF ECHOPULSE® FOR NON-INVASIVE TREATMENT OF BREAST FIBROADENOMAS​

* ‍OVER 25% OF PATIENTS HAVE ALREADY BEEN TREATED IN THIS PIVOTAL TRIAL​

* ‍TRIAL WILL ENROLL APPROXIMATELY 100 PATIENTS AT FOUR CENTERS IN U.S.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below